Education
About Us
Working with TipRanks
Follow Us
NanoViricides (NNVC)
XASE:NNVC
Total Valuation
NanoViricides has a market cap or net worth of $26.74M. The enterprise value is $16.71M.
Market Cap$26.74M
Enterprise Value$16.71M
Share Statistics
NanoViricides has 21,568,430 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,568,430
Owned by Insiders5.85%
Owned by Institutions0.55%
Financial Efficiency
NanoViricides’s return on equity (ROE) is -1.26 and return on invested capital (ROIC) is -127.59%.
Return on Equity (ROE)-1.26
Return on Assets (ROA)-1.07
Return on Invested Capital (ROIC)-127.59%
Return on Capital Employed (ROCE)-1.28
Revenue Per Employee0.00
Profits Per Employee-1.35M
Employee Count7
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of NanoViricides is ―. NanoViricides’s PEG ratio is 0.22.
PE Ratio―
PS Ratio0.00
PB Ratio2.82
Price to Fair Value2.82
Price to FCF-2.48
Price to Operating Cash Flow>-0.01
PEG Ratio0.22
Income Statement
In the last 12 months, NanoViricides had revenue of 0.00 and earned -9.47M in profits. Earnings per share was -0.63.
Revenue0.00
Gross Profit0.00
Operating Income-9.59M
Pretax Income-9.47M
Net Income-9.47M
EBITDA-8.72M
Earnings Per Share (EPS)-0.63
Cash Flow
In the last 12 months, operating cash flow was -7.48M and capital expenditures -94.52K, giving a free cash flow of -7.57M billion.
Operating Cash Flow-7.48M
Free Cash Flow-7.57M
Free Cash Flow per Share-0.35
Dividends & Yields
NanoViricides pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.60
52-Week Price Change-17.22%
50-Day Moving Average1.43
200-Day Moving Average1.42
Relative Strength Index (RSI)45.99
Average Volume (3m)143.34K
Important Dates
NanoViricides upcoming earnings date is Nov 23, 2026, Before Open (Confirmed).
Last Earnings DateNov 24, 2025
Next Earnings DateNov 23, 2026
Ex-Dividend Date―
Financial Position
NanoViricides as a current ratio of 1.28, with Debt / Equity ratio of 0.00%
Current Ratio1.28
Quick Ratio1.28
Debt to Market Cap0.00
Net Debt to EBITDA0.18
Interest Coverage Ratio-0.06
Taxes
In the past 12 months, NanoViricides has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
NanoViricides EV to EBITDA ratio is -2.25, with an EV/FCF ratio of -2.30.
EV to Sales0.00
EV to EBITDA-2.25
EV to Free Cash Flow-2.30
EV to Operating Cash Flow-2.31
Balance Sheet
NanoViricides has $1.13M in cash and marketable securities with $0.00 in debt, giving a net cash position of $1.13M billion.
Cash & Marketable Securities$1.13M
Total Debt$0.00
Net Cash$1.13M
Net Cash Per Share$0.05
Tangible Book Value Per Share$0.48
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for NanoViricides is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.00
Price Target Upside380.00% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast32.92%